Literature DB >> 10397216

Low systemic vascular resistance state in patients undergoing cardiopulmonary bypass.

A S Kristof1, S Magder.   

Abstract

OBJECTIVE: To determine the prevalence, hemodynamic characteristics, and risk factors for the low systemic vascular resistance (SVR) state in patients who have undergone cardiopulmonary bypass.
DESIGN: Prospective cohort study.
SETTING: The intensive care unit of a tertiary care hospital. PATIENTS: Seventy-nine consecutive patients who underwent coronary artery bypass graft, mitral valve, or aortic valve procedures.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Low SVR was defined as an indexed systemic vascular resistance (SVRi) of <1800 dyne x sec/cm5 x m2 at two consecutive times postoperatively. SVRi, cardiac index, mean arterial pressure, temperature, and central venous pressure were recorded before bypass and at 0, 1, 2, 4, 8, and 16 hrs after bypass. We recorded age, gender, urgency of operation, use of angiotensin-converting enzyme inhibitors and calcium channel blockers, ejection fraction, pump time, cross-clamp time, use of antifibrinolytics, type of oxygenator, amrinone use, postoperative biochemical and hematologic values, medication use, fluid balance, intensive care unit admission duration, and hospital admission duration. We assessed the role of diabetes mellitus, current smoking, and systemic hypertension. The incidence of the low-SVR state was 35 of 79 patients during a 3-month period (44%). At 8 hrs postoperatively, the SVRi in low-SVR and non-low-SVR patients was 1594+/-50 (SEM) and 2103+/-56 (SEM) dyne x sec/cm5 x m2, respectively (p < .001). In low-SVR patients, there was an initial and sustained increase in cardiac index and central venous pressure that preceded the decrease in mean arterial pressure. The decrease in mean arterial pressure was maximal at 8 hrs postoperatively. Patients with low SVR were more likely to have longer cross-clamp times, to be male, and to have lower postoperative platelet counts (p < .05 for all). Low-SVR patients were less likely to require dobutamine in the first 4 hrs postoperatively.
CONCLUSIONS: Low SVR, a probable manifestation of systemic inflammatory response syndrome, is common in patients after cardiopulmonary bypass. These patients may respond better to a vasopressor to restore vascular tone than to volume loading to further increase cardiac index.

Entities:  

Mesh:

Year:  1999        PMID: 10397216     DOI: 10.1097/00003246-199906000-00033

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  10 in total

1.  Safety, efficacy and response to a hydrocortisone rescue therapy protocol in children with refractory hypotension after cardiopulmonal bypass.

Authors:  F Neunhoeffer; H Renk; M Hofbeck; Ch Grenz; Ch Haller; E Heimberg; I Gerbig; Ch Schlensak; M Kumpf
Journal:  Pediatr Cardiol       Date:  2014-11-08       Impact factor: 1.655

2.  Intraoperative reduction of vasopressors using processed electroencephalographic monitoring in patients undergoing elective cardiac surgery: a randomized clinical trial.

Authors:  C Sponholz; C Schuwirth; L Koenig; H Hoyer; S M Coldewey; C Schelenz; T Doenst; A Kortgen; M Bauer
Journal:  J Clin Monit Comput       Date:  2019-02-19       Impact factor: 2.502

3.  Effects of norepinephrine on renal perfusion, filtration and oxygenation in vasodilatory shock and acute kidney injury.

Authors:  Bengt Redfors; Gudrun Bragadottir; Johan Sellgren; Kristina Swärd; Sven-Erik Ricksten
Journal:  Intensive Care Med       Date:  2010-10-15       Impact factor: 17.440

4.  Procalcitonin in patients undergoing cardiopulmonary bypass in open heart surgery-first results of the Procalcitonin in Heart Surgery study (ProHearts).

Authors:  M Loebe; S Locziewski; F M Brunkhorst; C Harke; R Hetzer
Journal:  Intensive Care Med       Date:  2000-03       Impact factor: 17.440

5.  Perioperative monitoring of circulating and central blood volume in cardiac surgery by pulse dye densitometry.

Authors:  Frank Bremer; Albert Schiele; Jan Sagkob; Thomas Palmaers; Klaus Tschaikowsky
Journal:  Intensive Care Med       Date:  2004-09-18       Impact factor: 17.440

6.  Norepinephrine for hypotensive vasodilatation after cardiac surgery: impact on renal function.

Authors:  Hiroshi Morimatsu; Shigehiko Uchino; John Chung; Rinaldo Bellomo; Jai Raman; Brian Buxton
Journal:  Intensive Care Med       Date:  2003-05-22       Impact factor: 17.440

Review 7.  Renal oxygenation in clinical acute kidney injury.

Authors:  Sven-Erik Ricksten; Gudrun Bragadottir; Bengt Redfors
Journal:  Crit Care       Date:  2013-03-19       Impact factor: 9.097

8.  Novel polymorphism of interleukin-18 associated with greater inflammation after cardiac surgery.

Authors:  David M Shaw; Ainsley M Sutherland; James A Russell; Samuel V Lichtenstein; Keith R Walley
Journal:  Crit Care       Date:  2009-01-29       Impact factor: 9.097

9.  Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: a case control study followed by a randomized double-blind controlled trial.

Authors:  Juan J Jimenez; Jose L Iribarren; Leonardo Lorente; Jose M Rodriguez; Domingo Hernandez; Ibrahim Nassar; Rosalia Perez; Maitane Brouard; Antonio Milena; Rafael Martinez; Maria L Mora
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

10.  Potential risks in using midodrine for persistent hypotension after cardiac surgery: a comparative cohort study.

Authors:  Jan-Alexis Tremblay; Philippe Laramée; Yoan Lamarche; André Denault; William Beaubien-Souligny; Anne-Julie Frenette; Loay Kontar; Karim Serri; Emmanuel Charbonney
Journal:  Ann Intensive Care       Date:  2020-09-14       Impact factor: 6.925

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.